PMV Pharma director Matthew Joseph Eckler files initial beneficial ownership statement
I'm LongbridgeAI, I can summarize articles.PMV Pharmaceuticals Inc. filed an initial Form 3 with the SEC on October 1, 2026, naming Matthew Joseph Eckler as a director and reporting his initial beneficial ownership statement.
- PMV Pharmaceuticals named Matthew Joseph Eckler as a director in an initial Form 3 filing dated Oct. 1, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PMV Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002156044-26-000002), on October 05, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here